BDTX logo

BDTX Shareholders Equity

Annual Shareholders Equity

$83.28 M
-$33.45 M-28.66%

December 31, 2024


Summary


Performance

BDTX Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBDTXbalance sheetmetrics:

Quarterly Shareholders Equity

$83.28 M
-$14.14 M-14.51%

December 31, 2024


Summary


Performance

BDTX Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBDTXbalance sheetmetrics:

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

BDTX Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-28.7%0.0%
3 y3 years-57.5%0.0%
5 y5 years+276.6%0.0%

BDTX Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-57.5%at low-57.5%+1.3%
5 y5-year-72.9%+276.6%-76.6%+276.6%
alltimeall time-72.9%+276.6%-76.6%+276.6%

Black Diamond Therapeutics Shareholders Equity History

DateAnnualQuarterly
Dec 2024
$83.28 M(-28.7%)
$83.28 M(-14.5%)
Sep 2024
-
$97.43 M(-12.2%)
Jun 2024
-
$111.02 M(+6.4%)
Mar 2024
-
$104.31 M(-10.6%)
Dec 2023
$116.74 M(+0.9%)
$116.74 M(-13.1%)
Sep 2023
-
$134.32 M(+63.4%)
Jun 2023
-
$82.20 M(-16.3%)
Mar 2023
-
$98.19 M(-15.1%)
Dec 2022
$115.69 M(-40.9%)
$115.69 M(-13.2%)
Sep 2022
-
$133.23 M(-12.6%)
Jun 2022
-
$152.37 M(-11.7%)
Mar 2022
-
$172.56 M(-11.9%)
DateAnnualQuarterly
Dec 2021
$195.90 M(-36.3%)
$195.90 M(-10.5%)
Sep 2021
-
$218.95 M(-12.8%)
Jun 2021
-
$251.02 M(-10.6%)
Mar 2021
-
$280.75 M(-8.8%)
Dec 2020
$307.76 M(-752.6%)
$307.76 M(-6.0%)
Sep 2020
-
$327.35 M(-4.6%)
Jun 2020
-
$343.13 M(-3.4%)
Mar 2020
-
$355.26 M(-853.4%)
Dec 2019
-$47.16 M(+203.4%)
-$47.16 M(-162.0%)
Sep 2019
-
$76.09 M(-589.6%)
Dec 2018
-$15.54 M(+132.8%)
-$15.54 M
Dec 2017
-$6.67 M
-

FAQ

  • What is Black Diamond Therapeutics annual stockholders equity?
  • What is the all time high annual shareholders equity for Black Diamond Therapeutics?
  • What is Black Diamond Therapeutics annual shareholders equity year-on-year change?
  • What is Black Diamond Therapeutics quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Black Diamond Therapeutics?
  • What is Black Diamond Therapeutics quarterly shareholders equity year-on-year change?

What is Black Diamond Therapeutics annual stockholders equity?

The current annual shareholders equity of BDTX is $83.28 M

What is the all time high annual shareholders equity for Black Diamond Therapeutics?

Black Diamond Therapeutics all-time high annual stockholders equity is $307.76 M

What is Black Diamond Therapeutics annual shareholders equity year-on-year change?

Over the past year, BDTX annual stockholders equity has changed by -$33.45 M (-28.66%)

What is Black Diamond Therapeutics quarterly stockholders equity?

The current quarterly shareholders equity of BDTX is $83.28 M

What is the all time high quarterly shareholders equity for Black Diamond Therapeutics?

Black Diamond Therapeutics all-time high quarterly stockholders equity is $355.26 M

What is Black Diamond Therapeutics quarterly shareholders equity year-on-year change?

Over the past year, BDTX quarterly stockholders equity has changed by $0.00 (0.00%)